U.S. Markets closed

TransMedics Group, Inc. (TMDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
14.79+0.19 (+1.30%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close14.60
Open14.47
Bid13.80 x 2200
Ask16.00 x 1100
Day's Range14.47 - 15.08
52 Week Range10.10 - 20.99
Volume30,168
Avg. Volume158,198
Market Cap401.708M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.36
Earnings DateNov 04, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.20
  • TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call Transcript
    Motley Fool

    TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to the TransMedics Q3 2020 Earnings Call. Earlier today TransMedics released financials results for the quarter ended September 30, 2020. Before we begin, I'd like to remind you that management will make statements during this call, that include forward-looking statements, within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

  • TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates

    TransMedics (TMDX) delivered earnings and revenue surprises of 42.42% and 19.58%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

  • TransMedics Reports Third Quarter 2020 Financial Results
    PR Newswire

    TransMedics Reports Third Quarter 2020 Financial Results

    TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported financial results for the quarter ended September 30, 2020.